| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 3.705 | 29.971 | 128.065 | 289.215 | 402.628 |
| Total Income - EUR | - | - | - | - | - | 3.705 | 29.971 | 128.109 | 294.685 | 402.657 |
| Total Expenses - EUR | - | - | - | - | - | 2.656 | 22.474 | 82.088 | 203.451 | 342.961 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 1.049 | 7.497 | 46.022 | 91.235 | 59.696 |
| Net Profit/Loss - EUR | - | - | - | - | - | 969 | 6.894 | 45.148 | 88.485 | 49.378 |
| Employees | - | - | - | - | - | 0 | 0 | 2 | 6 | 7 |
Check the financial reports for the company - Neuropraxis Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 2.327 | 3.627 | 8.976 | 185.302 |
| Current Assets | - | - | - | - | - | 3.913 | 4.163 | 48.206 | 93.819 | 26.974 |
| Inventories | - | - | - | - | - | 3.774 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 2.803 | 31.272 | 37.434 | 3.259 |
| Cash | - | - | - | - | - | 140 | 1.360 | 16.933 | 56.386 | 23.715 |
| Shareholders Funds | - | - | - | - | - | 1.011 | 7.882 | 48.999 | 88.817 | 107.544 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 12.627 | 6.287 | 8.703 | 18.003 | 106.823 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuropraxis Med S.r.l.